Abstract:The gut microbiota influences the effectiveness and side effects of cancer treatments, particularly immunotherapy and associated immune-related complications. This important involvement of the microbiome is supported by the patients receiving antibiotics responding poorly to immunotherapy. Relatively few research has examined the underlying processes, and until recently, data regarding the detection of the microbial organisms that trigger these effects were inconsistent. Since then, a deeper comprehension of the processes of action and taxonomic classification of the relevant species has been attained. It's been demonstrated that certain bacterial species can enhance the body's reaction to immune checkpoint inhibitors through the release of distinct metabolites or products. Nonetheless, in certain patients who are not responding, Gram-negative bacteria may have a dominating suppressive impact. Patients' propensity to react to immunotherapy can be somewhat accurately predicted by machine learning techniques based on their microbiome makeup. Consequently, there has been an increase in interest in modifying the microbiome makeup to enhance patient reaction to medication. Clinical proof-of-concept studies demonstrate that dietary modifications or fecal microbiota transplantation (FMT) might be used therapeutically to increase the efficacy of immunotherapy in cancer patients. Current developments and new approaches for microbiota-based cancer treatments have been emphasized. In conclusion, preclinical research on animals and human clinical trials has made tremendous progress in our understanding of the function of the gut microbiome in health and illness. These investigations have shed light on the effects of food, FMT, probiotics, prebiotics, and microbiome-disease connections. However, there are still a lot of issues and restrictions that must be resolved before this research can be used in real-world clinical settings.

Gut microbiota modulation of chemotherapy efficacy and toxicity

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?

Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy

Targeting the gut microbiota for cancer therapy

The role of gut microbiota and metabolites in cancer chemotherapy

The role of gut microbiota in cancer treatment: friend or foe?

Gut microbiota: impacts on gastrointestinal cancer immunotherapy

The gut microbiome modulate response to immunotherapy in cancer

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies

Gut Microbial Metabolites in Cancer Therapy

The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect

Gut microbiota modulation: a tool for the management of colorectal cancer

Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects

Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers

Interaction of the Gut Microbiome With Cancer Treatment

Novel strategies for modulating the gut microbiome for cancer therapy

Research progress on the effect of gut and tumor microbiota on antitumor efficacy and adverse effects of chemotherapy drugs

Role of Gut Microbiome in Cancer Treatment